ロード中...
MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer
Tamoxifen is an endocrine therapy which is administered to up to 70% of all breast cancer patients with oestrogen receptor alpha (ERα) expression. Despite the initial response, most patients eventually acquire resistance to the drug. MicroRNAs (miRNAs) are a class of small non-coding RNAs which have...
保存先:
| 出版年: | J Pathol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd.
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4298809/ https://ncbi.nlm.nih.gov/pubmed/24752803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/path.4363 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|